Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Gonadotrophin hormone releasing analogues open new doors in cancer treatment.

× No keyword cloud information.

20 in total

1. Protection from cyclophosphamide-induced testicular damage with an analogue of gonadotropin-releasing hormone.

Authors: L M Glode; J Robinson; S F Gould
Journal: Lancet Date: 1981-05-23 Impact factor: 79.321

2. Failure of long term luteinising hormone releasing hormone treatment for prostatic cancer to suppress serum luteinising hormone and testosterone.

Authors: D Kerle; G Williams; H Ware; S R Bloom
Journal: Br Med J (Clin Res Ed) Date: 1984-08-25

3. Advanced carcinoma of the prostate: treatment with a gonadotrophin releasing hormone agonist.

Authors: J M Allen; J P O'Shea; K Mashiter; G Williams; S R Bloom
Journal: Br Med J (Clin Res Ed) Date: 1983-05-21

4. Failure to preserve fertility in patients with Hodgkin's disease.

Authors: J H Waxman; R Ahmed; D Smith; P F Wrigley; W Gregory; S Shalet; D Crowther; L H Rees; G M Besser; J S Malpas
Journal: Cancer Chemother Pharmacol Date: 1987 Impact factor: 3.333

5. Tumor growth inhibition in patients with prostatic carcinoma treated with luteinizing hormone-releasing hormone agonists.

Authors: G Tolis; D Ackman; A Stellos; A Mehta; F Labrie; A T Fazekas; A M Comaru-Schally; A V Schally
Journal: Proc Natl Acad Sci U S A Date: 1982-03 Impact factor: 11.205

6. Sustained suppression of testosterone production by the luteinising-hormone releasing-hormone agonist buserelin in patients with advanced prostate carcinoma. A new therapeutic approach?

Authors: V Borgmann; W Hardt; M Schmidt-Gollwitzer; H Adenauer; R Nagel
Journal: Lancet Date: 1982-05-15 Impact factor: 79.321

7. Treatment with a luteinising-hormone-releasing-hormone analogue (buserelin) in premenopausal patients with metastatic breast cancer.

Authors: J G Klijn; F H de Jong
Journal: Lancet Date: 1982-05-29 Impact factor: 79.321

8. Regression of rat mammary tumors effected by a gonadoliberin analog.

Authors: E R DeSombre; E S Johnson; W F White
Journal: Cancer Res Date: 1976-10 Impact factor: 12.701

9. The influence of hormonal therapy on survival of men with advanced prostatic cancer.

Authors: H Lepor; A Ross; P C Walsh
Journal: J Urol Date: 1982-08 Impact factor: 7.450

10. Treatment with gonadotrophin releasing hormone analogue in advanced prostatic cancer.

Authors: J H Waxman; J A Wass; W F Hendry; H N Whitfield; G M Besser; J S Malpas; R T Oliver
Journal: Br Med J (Clin Res Ed) Date: 1983-04-23

3 in total

1. The effects of gonadotrophin releasing hormone analogues in prostate cancer are mediated through specific tumour receptors.

Authors: A Qayum; W Gullick; R C Clayton; K Sikora; J Waxman
Journal: Br J Cancer Date: 1990-07 Impact factor: 7.640

Review 2. The current status of scientific research and hormonal treatments for carcinoma of the prostate.

Authors: J Waxman; A Saini
Journal: Br J Cancer Date: 1991-09 Impact factor: 7.640

3. Treatment of high risk Sertoli-Leydig cell tumors of the ovary using a gonadotropin releasing hormone (GnRH) analog.

Authors: Harsha Prasada Lashkari; Ruth Nash; Assunta Albanese; Bruce Okoye; Robert Millar; Kathy Pritchard-Jones
Journal: Pediatr Blood Cancer Date: 2012-11-28 Impact factor: 3.167

3 in total